EHRA Premium Access

Atrial fibrillation and ablation or devices: what do registries tell us?

Event: EHRA EUROPACE - CARDIOSTIM 2017
Topic: Databases, Registries and Surveys
Session type: New ESC Guidelines
Date: 18 June 2017
Time: 08:30 - 10:00

Congress Session

5 presentations in this session

EORP registry: what determines a good outcome from atrial fibrillation ablation in the 'real world'.

Speaker: Doctor N. Dagres (Leipzig, DE)
Thumbnail

European Atrial Fibrillation Ablation Registry: do outcomes in the real-world compare with trials ?

Speaker: Professor J. Kautzner (Prague, CZ)
Thumbnail

Epicardial/hybrid atrial fibrillation ablation registry (EHAFAR): how does a hybrid approach compare to a transcatheter approach ?

Speaker: Professor C. Blomstrom-Lundqvist (Orebro, SE)
Thumbnail

Practice in perspective: can registry data guide future developments in atrial fibrillation ablation?

Speaker: Doctor J. de Bono (Birmingham, GB)
Thumbnail

Preventing progression of atrial fibrillation: a real-world analysis of a reactive atrial-antitachycardia pacing feature in CIEDs

Speaker: Professor G. Boriani (Modena, IT)
Thumbnail

5 speakers from this session

Doctor Nikolaos Dagres

Heart Center Leipzig at University of Leipzig, Leipzig (Germany)
21 presentations
1 follower

Professor Josef Kautzner

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)
27 presentations
3 followers

Professor Carina Blomstrom-Lundqvist

Orebro University Hospital, Orebro (Sweden)
28 presentations
3 followers

Doctor Joseph de Bono

Queen Elizabeth Hospital Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)
0 follower

Professor Giuseppe Boriani

Modena Polyclinic Modena University Hospital, Modena (Italy)
33 presentations
1 follower

This platform is supported by

logo Novo Nordisk